Solid Biosciences Inc.
SLDB· Nasdaq
Released Mar 15, 2021, after the close
10-K filed Mar 15, 2021, 74 days after period end · 0001564590-21-013153
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 | Q4 2017 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$21.36M | -$31.86M | -$21.92M | -$14.49M |
Solid Biosciences Inc. · CIK 1707502 · Engraved from SEC EDGAR
| EPS Diluted | — | -$0.67 | -$0.63 | -$0.84 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.